Aurigene Pharmaceutical Services offers formulation studies through a highly skilled scientific team. At our state-of-the-art facility, we handle complex oral solid dosage forms, oral liquids and parenteral dosage forms with ease and specialize in pediatric dosage forms and modified release dosage forms. With this, we provide you pre-clinical formulation, first in human formulation development and late-stage formulation studies
Our formulation development strategy is based on a thorough understanding of solid-state science to deliver ideal dosage forms. Our team is committed to deliver quality results in a time-bound and cost-effective manner at each stage of the development process.
Customers also select us, to evaluate container closure systems, storage and transportation conditions. ICH compliant stability studies and an extensive capacity along with a range of conditions to cover various climatic zones across the globe, make it possible to take decisions early in the drug development cycle.
Our range of formulation studies includes:
With decades of experience in formulation development, our scientists look forward to accelerating the time to market of your molecule.
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.